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ABSTRACT
Gastrointestinal metastases from breast cancer are rare and generally occur several years after the diagnosis of the primary 
lesion. The diagnosis of gastric metastasis as the initial presentation of breast cancer is even rarer and can potentially mimic 
gastric carcinoma. We report the case of a 66-year-old female patient submitted to a total gastrectomy because of the 
histological diagnosis of undifferentiated gastric carcinoma. During the surgical procedure, biopsies of the peritoneum 
and the liver were performed, which were consistent with metastatic breast invasive lobular carcinoma (ILC). The primary 
lesion of the breast was detected during the post-operative period, when a 4-cm-long lesion was detected on physical 
examination and mammography. The revision of the gastric biopsy confirmed the diagnosis of ILC. The authors call 
attention to the rarity of gastrointestinal metastases as the initial presentation of breast ILC. 
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INTRODUCTION
Metastatic breast cancer typically involves lymph 
nodes, bones, lung, liver, and brain.1 Gastrointestinal 
(GI) involvement and peritoneal carcinomatosis from 
primary breast cancer are rare with the incidence 
varying from 6% to 18% in autopsy series.2-5 In contrast 
to invasive ductal carcinoma (IDC), invasive lobular 
carcinoma (ILC) shows a distinct systemic metastatic 
pattern and has a higher incidence of metastases to 
the GI tract, gynecological organs, or peritoneum.6-8
Gastric metastases are slightly more frequent in 
autopsy reports;8,9 however, in the largest non-autopsy 
series involving women with breast cancer and GI 
metastases, 45% of the metastases involved the colon 
and the rectum, whereas the stomach accounted for 
28%.10 Metastatic involvement of the stomach may 
occur many years after the diagnosis of the breast 
cancer, and is often part of an extensive systemic 
dissemination.10,11 The diagnosis of gastric metastasis 
as the initial presentation of breast cancer is rare, 
potentially mimicking gastric carcinoma.12,13
We report the case of a patient presenting with 
a pre-operative diagnosis of undifferentiated gastric 
carcinoma that was confirmed, subsequently, as 
metastatic ILC of the breast.
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CASE REPORT
A 66-year-old woman presented with a 2-month 
history of epigastric pain, vomiting, and weight loss. 
The upper GI endoscopy demonstrated a circumferential 
lesion of body and antrum of the stomach with 
friable mucosa and areas of necrosis. A biopsy 
showed an undifferentiated neoplasm (Figure 1), 
which was initially diagnosed as adenocarcinoma by 
immunohistochemistry positivity for cytokeratin AE1/
AE3 and negativity for CD20 and CD3.
Subsequent abdominal computed tomography 
demonstrated parietal irregular thickening of the 
gastric wall, which was associated with densification 
of adjacent fat tissue determining gastric distension. 
The patient underwent a total gastrectomy accompanied 
by a lymphadenectomy and esophagojejunostomy with 
a Roux loop technique, a biopsy of the peritoneal 
lesions, and the resection of a liver nodule. In the 
post-operative period, a nodule in the lower medial 
quadrant of the left breast was evidenced on physical 
examination measuring 4 cm at its longest axis, which 
was subsequently evaluated by mammography and was 
irregular and spiculated. The histologic examination of 
the nodule’s biopsy revealed a low grade ILC, with the 
immunohistochemical positivity for estrogen receptors 
(90%), progesterone receptors (90%), negativity for 
Her2, E-cadherin, and Ki-67 of 10% (Figure 2).
The histological analysis of the stomach, 
peritoneum, and liver showed metastatic ILC (Figure 3). 
The material from the upper GI endoscopy was reviewed 
Figure 1. Photomicrography of the biopsy of the 
stomach showing an undifferentiated neoplasm, 
infiltrative cords, and isolated small cells around the 
oxyntic gastric mucosa (H&E, 100X).
Figure 2. Photomicrography of the breast nodule biopsy. A – Cords of small cells within the breast stroma 
(H&E, 200X); B – Infiltrating linear cords of cells E-cadherin negative around a positive normal breast duct (E-cadherin, 
200X); C – Progesterone receptor positivity in neoplastic cells (progesterone receptor, 200X); D – Estrogen receptor 
positivity in neoplastic cells (estrogen receptor, 200X).
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and submitted to a new immunohistochemical panel 
showing positivity for cytokeratin 7 and estrogen 
receptors, and negativity for cytokeratin 20 and CDX-2, 
which was consistent with metastatic ILC.
The patient is currently being treated with 
anti-estrogen therapy (letrozole).
DISCUSSION
Breast cancer is one of the most common 
malignancies that metastasizes to the GI tract, along 
with melanoma and lung carcinoma.2,14 GI metastasis is 
far more commonly associated with ILC than IDC of the 
breast. During a 15-year study reported by a research 
team from Mayo Clinic in 2005, of the 53 patients 
with breast cancer and GI metastasis 64% were due 
to ILC.10 The loss of expression of E-cadherin in ILC 
is a probable explanation for this peculiar metastatic 
pattern compared with IDC.15
The metastasis to the GI tract generally occurs 
several years after the diagnosis of the primary breast 
lesion.10,11,16 McLemore et al.,10 in a retrospective 
review of 73 patients with breast cancer and GI tract 
or peritoneum metastasis, reported a median interval 
of 7 years between the primary diagnosis of breast 
cancer and GI metastatic presentation.
In our case, it seemed more reasonable to accept 
the diagnosis of gastric neoplasm, since there was a 
lack of previous history of breast malignancy, and 
the clinical presentation of gastric metastasis (from a 
breast cancer) is often indistinguishable from primary 
gastric cancer. The most frequent symptoms are 
anorexia, epigastric pain, dyspepsia, weight loss, 
vomiting, and melena.10,11,17 The endoscopic findings 
also may be very similar to primary gastric carcinoma.11 
The most common pattern is a linitis plastica with 
diffuse infiltration of the submucosa and muscularis 
propria.11,18 However, the spectrum of endoscopic 
findings is large and includes polyps,11,18,19 erosions,20 
ulcer lesions,21 and sometimes a normal exam.22
It is important to differentiate GI metastatic breast 
cancer from a potential surgically resectable primary 
gastric cancer. The histological features of a metastatic 
breast lobular carcinoma to the stomach consist of 
the infiltration of the gastric tissue by non-cohesive 
small tumor cells with an occasional intracytoplasmic 
lumen arranged in linear cords between the normal 
gastric glands.23 The signet ring morphology of lobular 
breast carcinoma may mimic that of the primary gastric 
cancer. Therefore, immunohistochemical staining is 
essential to reach the final diagnosis when a metastatic 
lesion is suspected. Metastatic breast carcinomas are 
usually positive for cytokeratin 7, estrogen receptors, 
progesterone receptors, GCDFP-15, and are negative 
for cytokeratin 20.16,24
Systemic therapy is the treatment for breast 
cancer that is metastatic to the stomach and other 
sites. The choice of systemic treatment (chemotherapy, 
hormonal therapy, or both) is based upon symptoms, 
age, performance status, and previous systemic 
treatments. Taal et al.11 reported a 46% response rate 
(17 out of 37 patients with gastric metastasis) in their 
patients treated with systemic therapy. The response 
Figure 3. Photomicrography of the peritoneal biopsy. A – Infiltrating linear cords of small malignant cells within the 
adipose tissue (H&E, 200X); B – Negative reaction for E-cadherin (E-cadherin, 200X).
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to hormonal treatment and chemotherapy was similar 
in their group of patients. Palliative surgery is only 
recommended in cases of gastric obstruction.10,11 In the 
McLemore et al.10 series, 64% (47 out of 73 patients) 
underwent palliative surgical interventions for 
obstructive symptoms or mass effect. However, surgical 
palliation did not significantly improve the overall 
survival. Median overall survival of patients with gastric 
metastasis of the breast is equivalent to that of all 
women with metastatic breast disease, ranging from 
24 to 36 months.10
Metastatic breast cancer involving the GI tract 
can produce a wide range of clinical and radiological 
presentations, often mimicking a GI malignancy. 
This report presents the case of a gastric metastasis 
as the first manifestation of an ILC of the breast. 
Unlike the majority of previously reported cases, in 
which the primary breast carcinoma had been well 
recognized, the breast lesion in this case was found 
after the metastatic approach. Despite the size of the 
breast lesion, the misdiagnosis most likely occurred 
because the patient’s complaints were restricted to the 
dyspeptic symptoms, and a thorough examination was 
not performed. Breast examination should be carried 
out in all women with suspected neoplasia.
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